ciclopirox and loceryl

ciclopirox has been researched along with loceryl in 34 studies

Research

Studies (34)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (5.88)18.2507
2000's11 (32.35)29.6817
2010's19 (55.88)24.3611
2020's2 (5.88)2.80

Authors

AuthorsStudies
Baran, R1
Cohen, PR; Scher, RK1
Baran, R; Gupta, AK; Ryder, JE1
Reinel, D1
Sidou, F; Soto, P1
Baran, R; Kaoukhov, A1
Adjadj, L; Jäckel, A; Lambert, J; Marty, JP1
Macura, AB; Pawlik, B; Szczepko, I1
Gensbügel, C; Jäckel, A; Neubert, RH; Wartewig, S1
Carrillo-Muñoz, AJ; Del Valle, O; Eraso, E; Ezkurra, PA; Giusiano, G; Guardia, C; Hernández-Molina, JM; Quindós, G; Santos, P; Tur-Tur, C1
Cantrell, W; Cathcart, S; Elewski, Be1
Budihardja, D; Freund, V; Mayser, P1
Burgalassi, S; Chetoni, P; Ghelardi, E; Mailland, F; Monti, D; Saccomani, L; Senesi, S1
Berger, U; Borelli, C; Jäckel, A; Schaller, M; Schmidt, S; Walker, B; Weindl, G1
Vera-Cabrera, L; Welsh, E; Welsh, O1
Brown, MB; Evans, CR; Jones, SA; Khengar, RH; Traynor, MJ; Turner, RB1
Kubota, N; Mukai, H; Nagasaka, S; Shibuya, K; Shimamura, T; Suzuki, T1
Dal Bo, L; Herranz, U; Monti, D; Subissi, A1
Ben Osman, A; Bienvenu, AL; Bulai-Livideanu, C; Cazeau, C; Coubetergues, H; Coustou, D; Doss, N; Fazaa, B; Lahfa, M; Mokthar, I; Nouira, R; Paul, C; Picot, S; Turki, H; Voisard, JJ; Zourabichvili, O1
Burgalassi, S; Chetoni, P; Mailland, F; Monti, D; Tampucci, S1
Lipner, S; Scher, RK1
Bulgheroni, A; Celandroni, F; Ghelardi, E; Gueye, SA; Mailland, F; Salvetti, S; Senesi, S1
Fothergill, AW; McCarthy, DI; Tavakkol, A; Wiederhold, NP1
Borelli, C; Jäckel, A; Müller, J; Polak, A; Schaller, M; Seidl, HP1
Borelli, C; Braunsdorf, C; Jäckel, A; Mailänder-Sanchez, D; Müller, J; Schaller, M1
Hossin, B; Murdan, S; Rizi, K1
Eichenfield, LF; Friedlander, SF1
Sarkany, M; Schaller, M; Sigurgeirsson, B1
Chakrabarti, A; Dogra, S; Mushtaq, K; Narang, T; Paul, RA; Rudramurthy, SM; Shankarnarayan, SA; Shaw, D1
Ghannoum, M; Kunze, G; Long, L; Osman-Ponchet, H; Sarkany, M1
Dhamoon, RK; Gupta, M; Popli, H1
Bagger, C; Endringer Pinto, F; Janfelt, C; Joly-Tonetti, N; Kunze, G; Osman-Ponchet, H; Thénot, JP1
Almeida, BCT; Baltazar, LM; Carmo, PHF; Dornelas, JCM; Ferreira, GF; Freitas, GJC; Peres, NTA; Santos, DA1

Reviews

8 review(s) available for ciclopirox and loceryl

ArticleYear
Topical and surgical treatment of onychomycosis.
    Journal of the American Academy of Dermatology, 1994, Volume: 31, Issue:3 Pt 2

    Topics: Administration, Topical; Antifungal Agents; Ciclopirox; Combined Modality Therapy; Debridement; Foot Dermatoses; Hand Dermatoses; Humans; Laser Therapy; Morpholines; Onychomycosis; Pyridones

1994
The use of topical therapies to treat onychomycosis.
    Dermatologic clinics, 2003, Volume: 21, Issue:3

    Topics: Administration, Cutaneous; Antifungal Agents; Ciclopirox; Humans; Morpholines; Onychomycosis; Pyridones; Randomized Controlled Trials as Topic

2003
Topical antifungal drugs for the treatment of onychomycosis: an overview of current strategies for monotherapy and combination therapy.
    Journal of the European Academy of Dermatology and Venereology : JEADV, 2005, Volume: 19, Issue:1

    Topics: Administration, Oral; Administration, Topical; Antifungal Agents; Ciclopirox; Clinical Trials as Topic; Drug Therapy, Combination; Humans; Morpholines; Onychomycosis; Pyridones; Risk Factors

2005
Onychomycosis and diabetes.
    Journal of the European Academy of Dermatology and Venereology : JEADV, 2009, Volume: 23, Issue:10

    Topics: Administration, Topical; Antifungal Agents; Ciclopirox; Diabetes Complications; Humans; Morpholines; Naphthalenes; Onychomycosis; Pyridones; Terbinafine

2009
Toenail onychomycosis in diabetic patients: issues and management.
    American journal of clinical dermatology, 2009, Volume: 10, Issue:4

    Topics: Administration, Oral; Administration, Topical; Antifungal Agents; Ciclopirox; Comorbidity; Diabetes Mellitus; Diabetic Foot; Drug Interactions; Drug Therapy, Combination; Fluconazole; Foot Dermatoses; Humans; Itraconazole; Morpholines; Naphthalenes; Onychomycosis; Prevalence; Pyridones; Risk Factors; Terbinafine; Therapies, Investigational; Treatment Outcome

2009
Onychomycosis.
    Clinics in dermatology, 2010, Mar-04, Volume: 28, Issue:2

    Topics: Administration, Cutaneous; Administration, Oral; Antifungal Agents; Ciclopirox; Drug Administration Schedule; Drug Therapy, Combination; Fluconazole; Foot Dermatoses; Humans; Itraconazole; Mitosporic Fungi; Morpholines; Naphthalenes; Onychomycosis; Pyridones; Pyrimidines; Terbinafine; Thiazoles; Triazoles; Voriconazole

2010
Pediatric Onychomycosis: The Emerging Role of Topical Therapy.
    Journal of drugs in dermatology : JDD, 2017, 02-01, Volume: 16, Issue:2

    Topics: Administration, Topical; Adult; Age Factors; Antifungal Agents; Child; Ciclopirox; Family; Humans; Imidazoles; Incidence; Ketoconazole; Lacquer; Morpholines; Naphthalenes; Onychomycosis; Prevalence; Pyridones; Recurrence; Terbinafine; Tinea Pedis; Treatment Outcome

2017
Novel Drug Delivery Strategies for the Treatment of Onychomycosis.
    Pharmaceutical nanotechnology, 2019, Volume: 7, Issue:1

    Topics: Administration, Topical; Antifungal Agents; Ciclopirox; Drug Carriers; Humans; Liposomes; Morpholines; Nail Diseases; Nanoparticles; Onychomycosis

2019

Trials

4 trial(s) available for ciclopirox and loceryl

ArticleYear
A randomized comparison of nail surface remanence of three nail lacquers, containing amorolfine 5%, ciclopirox 8% or tioconazole 28%, in healthy volunteers.
    International journal of tissue reactions, 2004, Volume: 26, Issue:1-2

    Topics: Adult; Antifungal Agents; Ciclopirox; Female; Humans; Imidazoles; Lacquer; Male; Morpholines; Nails; Onychomycosis; Pyridones; Soaps; Thumb

2004
Nail penetration and predicted mycological efficacy of an innovative hydrosoluble ciclopirox nail lacquer vs. a standard amorolfine lacquer in healthy subjects.
    Journal of the European Academy of Dermatology and Venereology : JEADV, 2013, Volume: 27, Issue:2

    Topics: Adult; Ciclopirox; Humans; Male; Middle Aged; Morpholines; Nails; Onychomycosis; Pyridones; Reference Values

2013
A multicenter, randomized, open-label, controlled study comparing the efficacy, safety and cost-effectiveness of a sequential therapy with RV4104A ointment, ciclopiroxolamine cream and ciclopirox film-forming solution with amorolfine nail lacquer alone in
    Dermatology (Basel, Switzerland), 2013, Volume: 227, Issue:2

    Topics: Adolescent; Adult; Aged; Antifungal Agents; Ciclopirox; Cost-Benefit Analysis; Drug Combinations; Drug Therapy, Combination; Female; Follow-Up Studies; Foot Dermatoses; Humans; Male; Middle Aged; Morpholines; Ointments; Onychomycosis; Pyridones; Retrospective Studies; Skin Cream; Time Factors; Treatment Outcome; Young Adult

2013
Patient-reported outcomes from two randomised studies comparing once-weekly application of amorolfine 5% nail lacquer to other methods of topical treatment in distal and lateral subungual onychomycosis.
    Mycoses, 2017, Volume: 60, Issue:12

    Topics: Administration, Topical; Adult; Aged; Antifungal Agents; Ciclopirox; Drug Administration Schedule; Female; Foot Dermatoses; Humans; Imidazoles; Lacquer; Male; Medication Adherence; Middle Aged; Morpholines; Onychomycosis; Patient Reported Outcome Measures; Pyridones

2017

Other Studies

22 other study(ies) available for ciclopirox and loceryl

ArticleYear
[New treatments of onychomycoses].
    Annales de dermatologie et de venereologie, 1992, Volume: 119, Issue:3

    Topics: Administration, Topical; Antifungal Agents; Candidiasis; Ciclopirox; Fluconazole; Foot Dermatoses; Hand Dermatoses; Humans; Itraconazole; Ketoconazole; Morpholines; Onychomycosis; Pyridones

1992
[Onychomycosis].
    Der Hautarzt; Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete, 2004, Volume: 55, Issue:2

    Topics: Antifungal Agents; Ciclopirox; Debridement; Diagnosis, Differential; Drug Therapy, Combination; Fluconazole; Griseofulvin; Humans; Imidazoles; Itraconazole; Morpholines; Mycological Typing Techniques; Naphthalenes; Onychomycosis; Pyridones; Terbinafine; Time Factors

2004
Treatment costs of three nail lacquers used in onychomycosis.
    The Journal of dermatological treatment, 2005, Volume: 16, Issue:5-6

    Topics: Adult; Antifungal Agents; Ciclopirox; Drug Costs; Europe; Female; Foot Dermatoses; Hand Dermatoses; Humans; Imidazoles; Male; Morpholines; Onychomycosis; Pyridones

2005
[The susceptibility of Aspergillus and Penicillium to recent antimycotics].
    Wiadomosci parazytologiczne, 2000, Volume: 46, Issue:1

    Topics: Antifungal Agents; Aspergillus; Ciclopirox; Drug Resistance, Fungal; Itraconazole; Microbial Sensitivity Tests; Morpholines; Naphthalenes; Penicillium; Pyridones; Terbinafine

2000
Different physicochemical properties of antimycotic agents are relevant for penetration into and through human nails.
    Die Pharmazie, 2006, Volume: 61, Issue:7

    Topics: Antifungal Agents; Chemical Phenomena; Chemistry, Physical; Ciclopirox; Humans; Morpholines; Nails; Permeability; Pyridones; Solubility; Spectroscopy, Fourier Transform Infrared

2006
In vitro antifungal activity of sertaconazole nitrate against recent isolates of onychomycosis causative agents.
    Journal of chemotherapy (Florence, Italy), 2008, Volume: 20, Issue:4

    Topics: Antifungal Agents; Arthrodermataceae; Ciclopirox; Dose-Response Relationship, Drug; Fluconazole; Fungi; Humans; Imidazoles; Microbial Sensitivity Tests; Morpholines; Naphthalenes; Onychomycosis; Pyridones; Terbinafine; Thiophenes; Yeasts

2008
Hydrosoluble medicated nail lacquers: in vitro drug permeation and corresponding antimycotic activity.
    The British journal of dermatology, 2010, Feb-01, Volume: 162, Issue:2

    Topics: Absorption; Administration, Topical; Animals; Antifungal Agents; Cattle; Ciclopirox; Hoof and Claw; Humans; Lacquer; Morpholines; Nails; Onychomycosis; Permeability; Pharmaceutical Solutions; Pharmaceutical Vehicles; Pyridones; Regression Analysis; Solubility

2010
Susceptibility testing of amorolfine, bifonazole and ciclopiroxolamine against Trichophyton rubrum in an in vitro model of dermatophyte nail infection.
    Medical mycology, 2009, Volume: 47, Issue:7

    Topics: Administration, Topical; Antifungal Agents; Ciclopirox; Humans; Imidazoles; Microbial Sensitivity Tests; Models, Biological; Morpholines; Onychomycosis; Pyridones; Trichophyton

2009
Effect of a novel penetration enhancer on the ungual permeation of two antifungal agents.
    The Journal of pharmacy and pharmacology, 2010, Volume: 62, Issue:6

    Topics: Adenosine Triphosphate; Administration, Topical; Antifungal Agents; Cadaver; Ciclopirox; Humans; In Vitro Techniques; Morpholines; Nail Diseases; Nails; Naphthalenes; Onychomycosis; Permeability; Pyridones; Terbinafine

2010
Establishment of a novel model of onychomycosis in rabbits for evaluation of antifungal agents.
    Antimicrobial agents and chemotherapy, 2011, Volume: 55, Issue:7

    Topics: Animals; Antifungal Agents; Ciclopirox; Lacquer; Male; Models, Biological; Morpholines; Onychomycosis; Pyridones; Rabbits; Trichophyton

2011
[When the nail is the polished one].
    MMW Fortschritte der Medizin, 2012, May-31, Volume: 154, Issue:10

    Topics: Administration, Topical; Antifungal Agents; Ciclopirox; Combined Modality Therapy; Disease Progression; Humans; Morpholines; Onychomycosis; Pyridones

2012
Ciclopirox vs amorolfine: in vitro penetration into and permeation through human healthy nails of commercial nail lacquers.
    Journal of drugs in dermatology : JDD, 2014, Volume: 13, Issue:2

    Topics: Administration, Topical; Antifungal Agents; Chromatography, High Pressure Liquid; Ciclopirox; Fungi; Humans; In Vitro Techniques; Microbial Sensitivity Tests; Morpholines; Nails; Permeability; Pyridones

2014
Onychomycosis: current and future therapies.
    Cutis, 2014, Volume: 93, Issue:2

    Topics: Antifungal Agents; Boron Compounds; Bridged Bicyclo Compounds, Heterocyclic; Ciclopirox; Debridement; Foot Dermatoses; Hand Dermatoses; Humans; Laser Therapy; Morpholines; Naphthalenes; Onychomycosis; Pyridones; Terbinafine; Triazoles

2014
Potential of Ergosterol synthesis inhibitors to cause resistance or cross-resistance in Trichophyton rubrum.
    Antimicrobial agents and chemotherapy, 2014, Volume: 58, Issue:5

    Topics: Antifungal Agents; Ciclopirox; Drug Resistance, Fungal; Ergosterol; Itraconazole; Microbial Sensitivity Tests; Morpholines; Naphthalenes; Pyridones; Terbinafine; Trichophyton

2014
Luliconazole demonstrates potent in vitro activity against dermatophytes recovered from patients with onychomycosis.
    Antimicrobial agents and chemotherapy, 2014, Volume: 58, Issue:6

    Topics: Antifungal Agents; Arthrodermataceae; Ciclopirox; Dermatomycoses; Humans; Imidazoles; Microbial Sensitivity Tests; Morpholines; Naphthalenes; Onychomycosis; Pyridones; Terbinafine

2014
Sporicidal effect of amorolfine and other antimycotics used in the therapy of fungal nail infections.
    Mycoses, 2015, Volume: 58, Issue:10

    Topics: Antifungal Agents; Candida albicans; Ciclopirox; Epidermophyton; Fluconazole; Hand Dermatoses; Humans; Keratins; Microbial Sensitivity Tests; Morpholines; Nails; Naphthalenes; Onychomycosis; Pyridones; Spores, Fungal; Terbinafine; Trichophyton

2015
Comparison of user-friendliness and treatment cost of Loceryl® vs. Ciclopoli®--a patient's perspective.
    Mycoses, 2015, Volume: 58, Issue:10

    Topics: Administration, Topical; Adult; Antifungal Agents; Ciclopirox; Foot Dermatoses; Germany; Health Care Costs; Humans; Male; Morpholines; Nails; Onychomycosis; Patient Satisfaction; Prospective Studies; Pyridones; Surveys and Questionnaires

2015
Application of Hansen Solubility Parameters to predict drug-nail interactions, which can assist the design of nail medicines.
    European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V, 2016, Volume: 102

    Topics: Adolescent; Adult; Antifungal Agents; Ciclopirox; Drug Interactions; Female; Humans; Keratins; Male; Middle Aged; Morpholines; Nail Diseases; Nails; Naphthalenes; Onychomycosis; Pharmaceutical Preparations; Pyridones; Solubility; Terbinafine; Triazoles; Young Adult

2016
Mutation in the Squalene Epoxidase Gene of Trichophyton interdigitale and Trichophyton rubrum Associated with Allylamine Resistance.
    Antimicrobial agents and chemotherapy, 2018, Volume: 62, Issue:5

    Topics: Allylamine; Antifungal Agents; Arthrodermataceae; Ciclopirox; Drug Resistance, Fungal; Fluconazole; Itraconazole; Microbial Sensitivity Tests; Morpholines; Squalene Monooxygenase; Terbinafine; Trichophyton; Voriconazole

2018
A pilot, layerwise, ex vivo evaluation of the antifungal efficacy of amorolfine 5% nail lacquer vs other topical antifungal nail formulations in healthy toenails.
    Mycoses, 2019, Volume: 62, Issue:6

    Topics: Administration, Topical; Allylamine; Antifungal Agents; Cadaver; Ciclopirox; Humans; Lacquer; Morpholines; Nails; Pilot Projects; Terbinafine; Trichophyton

2019
Visualisation of penetration of topical antifungal drug substances through mycosis-infected nails by matrix-assisted laser desorption ionisation mass spectrometry imaging.
    Mycoses, 2020, Volume: 63, Issue:8

    Topics: Administration, Topical; Allylamine; Antifungal Agents; Ciclopirox; Humans; Lacquer; Morpholines; Nails; Onychomycosis; Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization

2020
Reactive oxygen and nitrogen species are crucial for the antifungal activity of amorolfine and ciclopirox olamine against the dermatophyte Trichophyton interdigitale.
    Medical mycology, 2022, Aug-18, Volume: 60, Issue:8

    Topics: Animals; Antifungal Agents; Arthrodermataceae; Ciclopirox; Ergosterol; Microbial Sensitivity Tests; Morpholines; Nitrogen; Onychomycosis; Oxygen; Reactive Oxygen Species; Superoxide Dismutase; Trichophyton

2022